Engineer Creates 3D-Printed Breast Tissue for Cancer Survivors

Katie Weimer was just 15 when breast cancer took her mother at age 50. Now, nearly three decades later, the biomechanical engineer is turning that loss into hope for hundreds of thousands of women facing the same disease.

Weimer launched GenesisTissue in Colorado in 2024 with a mission to transform breast reconstruction. Her innovation: 3D-printed scaffolds made from cell-friendly biomaterials that help cancer survivors regrow their own natural breast tissue.

The process works by having surgeons extract a patient's fat cells through liposuction, then inject those cells into a custom-printed scaffold. Once implanted, the cells grow into natural tissue while the scaffold safely dissolves over time.

"The reality is so many women must live with a reminder of the cancer they had every single day," Weimer said. "That is not good enough."

The need is staggering. More than 300,000 women in the United States are diagnosed with breast cancer annually, with about 170,000 undergoing lumpectomies that often leave permanent scarring and deformities.

Current breast implants carry serious risks, including an FDA boxed warning about possible cancer development. These industrial materials aren't designed to last a lifetime and can be rejected by the body.

Weimer's approach is different. Each scaffold is personalized using computer scans of the tumor size, creating a perfect fit rather than forcing an off-the-shelf product into place.

Why This Inspires

Weimer isn't working alone. Researchers at Harvard, Penn State, and institutions worldwide are racing to perfect bioprinted tissue solutions because the demand is so urgent.

What sets Weimer apart is her personal connection. Her mother's memory drives her team to work every day toward giving survivors "the right to a breast reconstruction that regenerates into their own breast tissue and lasts a lifetime."

The technology isn't commercially available yet, but benchtop and preliminary preclinical data show promising results. Clinical trials could be on the horizon.

Meanwhile, the broader field of bioprinting is exploding with breakthroughs. A patient in South Korea received a 3D-printed windpipe in 2024, while researchers at UC San Diego are developing functional, patient-specific livers.

Weimer acknowledges she's part of a larger movement of scientists and engineers all pushing toward the same goal. She sees it as a shared race where everyone wins when any breakthrough happens.

"We are working every day fighting for breast cancer survivors," Weimer said, "and their right to become whole again."